Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1998 Aug;15(8):823-33.
doi: 10.1023/a:1006920219069.

Different O-glycosylation of respiratory mucin glycopeptides from a patient with cystic fibrosis

Affiliations
Case Reports

Different O-glycosylation of respiratory mucin glycopeptides from a patient with cystic fibrosis

K A Thomsson et al. Glycoconj J. 1998 Aug.

Abstract

The O-linked oligosaccharides from three fractions of highly glycosylated mucin glycopeptides obtained from sputum of a patient with cystic fibrosis were characterized and compared regarding size, composition, sequence and when possible linkage positions. Neutral and sialic acid-containing glycans were permethylated and analyzed by high-temperature GC-MS and MALDI-MS, showing more than 60 different oligosaccharides with a size of up to 15 monosaccharide units. Some of the observed oligosaccharides are novel for respiratory secretions, one being a trifucosylated heptasaccharide with the proposed structure: Fuc-Gal-4(Fuc-3)GlcNAc-(Fuc-)Gal-3GalNAcol. The glycosylation of two of the glycopeptide fractions was similar with regard to the neutral and sialylated oligosaccharides despite their different origins from the sol or gel phase. Analysis of the sulfated oligosaccharides by FAB-MS/MS indicated that the gel fraction contained C-6 linked sulfate groups while the two sol fractions also contained C-3 linked sulfate. The results suggest the presence of different glycosylated mucin domains, probably originating from different mucin glycoforms and/or apoproteins in the airway of cystic fibrosis patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Biochem. 1988 Nov 1;177(2):443-60 - PubMed
    1. Biochem J. 1996 Jun 15;316 ( Pt 3):967-75 - PubMed
    1. Biochem J. 1991 Jun 15;276 ( Pt 3):677-82 - PubMed
    1. Glycoconj J. 1995 Feb;12(1):69-76 - PubMed
    1. J Clin Invest. 1989 Jul;84(1):68-72 - PubMed

Publication types